Literature DB >> 33352963

Antimicrobial Constituents from Machaerium Pers.: Inhibitory Activities and Synergism of Machaeriols and Machaeridiols against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus faecium, and Permeabilized Gram-Negative Pathogens.

Ilias Muhammad1, Melissa R Jacob1, Mohamed A Ibrahim1, Vijayasankar Raman1, Mallika Kumarihamy1, Mei Wang1,2, Taha Al-Adhami3, Charlotte Hind4, Melanie Clifford4, Bethany Martin4, Jianping Zhao1, J Mark Sutton4, Khondaker Miraz Rahman3.   

Abstract

Two new epimeric bibenzylated monoterpenes machaerifurogerol (1a) and 5-epi-machaerifurogerol (1b), and four known isoflavonoids (+)-vestitol (2), 7-O-methylvestitol (3), (+)-medicarpin (4), and 3,8-dihydroxy-9-methoxypterocarpan (5) were isolated from Machaerium Pers. This plant was previously assigned as Machaerium multiflorum Spruce, from which machaeriols A-D (6-9) and machaeridiols A-C (10-12) were reported, and all were then re-isolated, except the minor compound 9, for a comprehensive antimicrobial activity evaluation. Structures of the isolated compounds were determined by full NMR and mass spectroscopic data. Among the isolated compounds, the mixture 10 + 11 was the most active with an MIC value of 1.25 μg/mL against methicillin-resistant Staphylococcus aureus (MRSA) strains BAA 1696, -1708, -1717, -33591, and vancomycin-resistant Enterococcus faecium (VRE 700221) and E. faecalis (VRE 51299) and vancomycin-sensitive E. faecalis (VSE 29212). Compounds 6-8 and 10-12 were found to be more potent against MRSA 1708, and 6, 11, and 12 against VRE 700221, than the drug control ciprofloxacin and vancomycin. A combination study using an in vitro Checkerboard method was carried out for machaeriols (7 or 8) and machaeridiols (11 or 12), which exhibited a strong synergistic activity of 12 + 8 (MIC 0.156 and 0.625 µg/mL), with >32- and >8-fold reduction of MIC's, compared to 12, against MRSA 1708 and -1717, respectively. In the presence of sub-inhibitory concentrations on polymyxin B nonapeptide (PMBN), compounds 10 + 11, 11, 12, and 8 showed activity in the range of 0.5-8 µg/mL for two strains of Acinetobacter baumannii, 2-16 µg/mL against Pseudomonas aeruginosa PAO1, and 2 µg/mL against Escherichia coli NCTC 12923, but were inactive (MIC > 64 µg/mL) against the two isolates of Klebsiella pneumoniae.

Entities:  

Keywords:  5-epi-machaerifurogerol; MRSA; Machaerium Rimachi 12161; VRE; gram negative bacteria; isoflavonoid; machaeridiol A–C; machaerifurogerol; machaeriol A–C

Year:  2020        PMID: 33352963      PMCID: PMC7765828          DOI: 10.3390/molecules25246000

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  2 in total

1.  Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways.

Authors:  Mallika Kumarihamy; Siddharth Tripathi; Premalatha Balachandran; Bharathi Avula; Jianping Zhao; Mei Wang; Maria M Bennett; Jin Zhang; Mary A Carr; K Michael Lovell; Ocean I Wellington; Mary E Marquart; N P Dhammika Nanayakkara; Ilias Muhammad
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

2.  Special Issue: "James D. McChesney, Vision, Passion and Leadership in the Development of Plant-Derived Natural Products".

Authors:  Larry A Walker; N P Dhammika Nanayakkara
Journal:  Molecules       Date:  2021-12-07       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.